呼吸系统疾病与肺癌风险的关联:英国生物银行队列二次分析
基于英国生物银行前瞻性队列的二次分析,纳入37–73岁参与者,中位随访10.44年,期间2189人发生肺癌。呼吸系统疾病与肺癌风险升高相关(HR 2.97,95%CI 2.75–3.21),急性呼吸道感染(如病毒性肺炎HR 9.86)显示强关联,中性粒细胞计数部分介导该关联(中介比例最高8%)。
要点
- 呼吸系统疾病患者肺癌风险升高近3倍(HR 2.97)。
- 急性呼吸道感染与肺癌发生强相关,病毒性肺炎HR达9.86。
- 中性粒细胞计数部分介导呼吸疾病与肺癌的关联。
核心结论
- 呼吸系统疾病尤其是急性呼吸道感染与肺癌发病率升高相关,提示可用于未来风险分层研究。
研究设计与样本
- 英国生物银行前瞻性队列二次分析,纳入2006–2010年22个评估中心招募的37–73岁参与者。
- 采用Cox比例风险模型估计肺癌发病HR,呼吸疾病状态基于住院记录定义。
- 进行中介分析探索生物标志物,并用孟德尔随机化评估因果关系。
主要发现
- 平均随访10.44年(4 790 738人年),2189人发生肺癌。
- 呼吸疾病组107 007人中1322例肺癌(发病率27.6/10 000人年),无呼吸疾病组351 876人中867例(7.9/10 000人年)。
- 呼吸疾病总体HR 2.97(95%CI 2.75–3.21)。
- 急性鼻咽炎HR 3.41(95%CI 1.83–6.34),流感HR 3.90(95%CI 2.53–6.01),病毒性肺炎HR 9.86(95%CI 6.55–14.85),细菌性肺炎HR 6.28(95%CI 4.40–8.96)。
- 鳞状细胞癌风险升高最显著(HR 3.65,95%CI 3.06–4.36);中性粒细胞计数部分中介关联(中介比例最高8%)。
临床怎么用
- 对呼吸系统疾病尤其急性呼吸道感染患者,应关注肺癌风险并考虑个体化筛查。
- 中性粒细胞计数可能作为部分介导指标,但中介比例有限,不宜单独用于风险预测。
局限性
- 为观察性二次分析,因果推断需谨慎。
- 呼吸疾病状态基于住院记录,可能低估轻症感染。
- 中介分析中介比例最高仅8%,提示其他机制待探索。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Introduction Respiratory diseases are significant risk factors for lung cancer; however, the association between acute respiratory infections and lung cancer incidence requires further exploration. Methods We performed a secondary analysis of the prospective UK Biobank cohort, including participants aged 37–73 years recruited from 22 assessment centres across the UK between 2006 and 2010. Cox proportional hazards models estimated HRs for incident lung cancer according to respiratory disease status, which was defined based on linked hospital inpatient records. Mediation analysis explored potential biomarkers, and Mendelian randomisation assessed causal relationships. Results During a mean follow-up of 10.44 years (4 790 738 person-years), 2189 participants developed lung cancer. Among 107 007 individuals with respiratory diseases, 1322 cases occurred (incidence rate 27.6 per 10 000 person-years), compared with 867 cases among 351 876 participants without respiratory diseases (7.9 per 10 000 person-years). Overall, respiratory diseases were associated with increased lung cancer risk (HR 2.97, 95% CI 2.75 to 3.21). Acute respiratory infections, including acute nasopharyngitis (HR 3.41; 95% CI 1.83 to 6.34), influenza (HR 3.90; 95% CI 2.53 to 6.01), viral pneumonia (HR 9.86; 95% CI 6.55 to 14.85) and bacterial pneumonia (HR 6.28; 95% CI 4.40 to 8.96), showed strong associations with lung cancer incidence. In subtype analyses, squamous cell carcinoma exhibited the highest risk elevation (HR 3.65; 95% CI 3.06 to 4.36). Mediation analysis indicated that neutrophil counts partially mediated these associations (proportion mediated up to 8%). Conclusion Acute respiratory infections were associated with higher lung cancer incidence, providing hypothesis-generating evidence that may inform future risk stratification research.
引用
- BMJ Open Respiratory Research:Associations between respiratory diseases and lung cancer risk: a secondary analysis of the large-scale prospective UK biobank cohort
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。